Zimbabwe

Active Projects: 1

Project Investigator All Locations Start date
 		End date
Targeted HIV/TB Strategic Information Technical Assistance for President's Emergency Plan for AIDS Relief (PEPFAR) and Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Countries George Rutherford, MD Ethiopia, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Botswana, Namibia, South Africa, Burkina Faso, Ivory Coast, Ghana, Liberia, Mali, Senegal, Sierra Leone, Togo, Dominican Republic, Haiti

Archived Projects: 121

Project Investigator All Locations Start date
 		End date
HIV Risk Reduction Through HSV-2 Prevention with N-9 Zimbabwe
The Zimbabwe-San Francisco HIV Prevention Trials Unit Zimbabwe
Hormonal Contraception and the Risk of HIV Acquisition Zimbabwe
Global Strategies for HIV Prevention Arthur Ammann, MD Zimbabwe, Congo (Kinshasa), Congo (Brazzaville), Liberia, India
Zimbabwe San Francisco HPTN Fogarty Training / International AIDS Training Program Zimbabwe
CFAR International Scientist Training Awards / International AIDS Training Program Paul Volberding, MD Zimbabwe, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru
HIV-Related Oral Diseases Among Women in Harare John Greenspan, BDS, PhD Zimbabwe
Preventing HIV by Protecting the Cervix Zimbabwe, South Africa
Improving Uses of New and Existing Technologies to Reduce Non-viral STIs in Developing Countries Zimbabwe
A Phase I Safety Trial of the Diaphragm in Zimbabwe Zimbabwe
Fogarty International AIDS Training Paul Volberding, MD Kenya, Uganda, Zimbabwe, Ivory Coast, India, Brazil, Peru
Providers' Perceptions of the Diaphragm in Southern Africa and the United States Cynthia Harper, PhD Zimbabwe, South Africa
Economic Opportunity for Zimbabwean Adolescent Orphans Philip Darney, MD, MS Zimbabwe
Community-Based HIV VCT: Zimbabwe Stephen Morin, PhD Tanzania, Zimbabwe, Southern Africa, Thailand, United States
International AIDS Education and Training Center E. Michael Reyes, MD, MPH Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Gabon, Egypt, Morocco, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea-Bissau, Mali, Niger, Nigeria, Senegal, Togo, Kyrgyzstan, China, Bangladesh, India, Iran, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Georgia, Iraq, Lebanon, Yemen, Czech Republic, Estonia, Greece, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Venezuela, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Puerto Rico, Trinidad and Tobago, Australia
International CAPS/Fogarty Visiting Scientists George Rutherford, MD Uganda, Zimbabwe, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru
Building Community Partnerships: Case Studies at Three HPTN Sites Stephen Morin, PhD Zimbabwe, Thailand, Peru
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Zvavahera Chirenje, MD, FRCOG Zimbabwe
Coming Together to Overcome HIV/AIDS in Zimbabwe and Zambia Zambia, Zimbabwe
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory Francesca Aweeka, PharmD Kenya, Malawi, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, India, Thailand, Brazil, Peru, Haiti, Puerto Rico, United States
Institute for Global Orthopedics and Traumatology (IGOT) Richard Coughlin, MD Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Seychelles, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Egypt, Morocco, Botswana, Namibia, South Africa, Ivory Coast, Ghana, Liberia, Mali, Niger, Nigeria, Sierra Leone, Kazakhstan, Tajikistan, Uzbekistan, China, Afghanistan, Bangladesh, India, Nepal, Viet Nam, Thailand, Philippines, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Brazil
International Maternal Adolescent AIDS Clinical Trials Group - Master Subcontract Diane Wara, MD Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, India, Thailand
Center for AIDS Prevention Studies Stephen Morin, PhD Kenya, Uganda, Tanzania, Zambia, Zimbabwe, South Africa, China, India, Iran, Nepal, Cambodia, Viet Nam, Myanmar, Thailand, Argentina, Peru
A Randomized Placebo-Controlled Trial to Evaluate the Effectiveness of Antiretroviral Therapy to Reduce Transmission of HIV-1 in Serodiscordant Couples Zimbabwe
University of Zimbabwe-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Zimbabwe
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD Kenya, Uganda, Tanzania, Zimbabwe, Ghana, Cambodia, Thailand, Nicaragua
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage Suellen Miller, PhD, CNM, MHA Zambia, Zimbabwe
UCSF-Gladstone Center for AIDS Research (CFAR) Paul Volberding, MD Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru
Non-Pneumatic Anti-Shock Garment for Obstetric Hemorrhage Suellen Miller, PhD, CNM, MHA Zambia, Zimbabwe
Duet and Menstrual Protection Ariane Van der Straten, PhD, MPH Zimbabwe
Safe Abortion Services and Advocacy in Zimbabwe and Tanzania J. Joseph Speidel, MD, MPH Tanzania, Zimbabwe
AIDS Policy Research Center Stephen Morin, PhD Tanzania, Zimbabwe, South Africa, Kazakhstan, China, Japan, India, Cambodia, Viet Nam, Thailand, Philippines, Croatia, South America, Argentina, Brazil, Peru, Antigua and Barbuda, Barbados, Saint Kitts and Nevis, Saint Vincent and the Grenadines
Community-based VCT: Zimbabwe Stephen Morin, PhD Tanzania, Zimbabwe, South Africa, Thailand
Congenital Syphilis Elimination Cost-Effectiveness Analysis James Kahn, MD, MPH Burundi, Comoros, Djibouti, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Brazzaville), Gabon, Sao Tome and Principe, Sudan, Tunisia, Botswana, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Ivory Coast, Ghana, Guinea, Mali, Nigeria, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Uzbekistan, China, Mongolia, Afghanistan, Bangladesh, India, Maldives, Nepal, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Philippines, Jordan, Oman, Saudi Arabia, Belarus, Czech Republic, Estonia, Germany, Hungary, Lithuania, Macedonia, Moldova, Romania, United Kingdom, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Uruguay, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Trinidad and Tobago, Fiji, Kiribati, Papua New Guinea
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Ivory Coast
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Thailand, Peru
CAPS/Fogarty Visiting Scientists and In-Country Research Training Activities George Rutherford, MD Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zambia, Zimbabwe, Egypt, Sudan, South Africa, Burkina Faso, Ghana, Nigeria, Senegal, Kazakhstan, China, Japan, India, Iran, Nepal, Cambodia, Indonesia, Viet Nam, Thailand, Philippines, Georgia, Jordan, Croatia, Czech Republic, Russia, Costa Rica, Guatemala, Mexico, Argentina, Brazil, Chile, Ecuador, Peru, Venezuela, Dominican Republic, Puerto Rico, Trinidad and Tobago, Canada
iBiology: Bringing the worlds best biology to you Ronald Vale, PhD Burundi, Kenya, Malawi, Mauritius, Rwanda, Seychelles, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Sudan, Botswana, Lesotho, Namibia, South Africa, Swaziland, Gambia, Ghana, Liberia, Nigeria, Sierra Leone, India, Nepal, Pakistan, Singapore, Philippines, Ireland, Malta, Belize, Guyana, Antigua and Barbuda, Bahamas, Barbados, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, American Samoa, Northern Mariana Islands, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu
M tuberculosis Cells from Patients with Tuberculosis Midori Kato-Maeda, MD Tanzania, Zimbabwe, Panama
Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage Suellen Miller, PhD, CNM, MHA Zambia, Zimbabwe
Role of the Informal Sector in Mixed Health Services Project Dominic Montagu, DrPH Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Ghana, Mali, Nigeria, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea
Microbicide Pregnancy Registry-Microbicide Trials Network Juan Vargas, MD Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Peru
UZ-UCSF Collaborative Research Program Suellen Miller, PhD, CNM, MHA Zimbabwe
UCSF-GIVI Center for AIDS Research . Paul Volberding, MD Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru
AIDS Malignancies Consortium Lawrence Kaplan, MD Kenya, Uganda, Zimbabwe, South Africa, India, Brazil, Australia
University of California Global Health Institute Women's Health and Empowerment Center of Expertise Post-Doctoral Fellowship Program Craig Cohen, MD, MPH Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, South Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Zimbabwe
Global Health Sciences Clinical Scholars Program Immersion Experience Christopher Stewart, MD Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, North Korea, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Israel, Jordan, Lebanon, Palestinian Territory, Syria, Turkey, Yemen, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Antigua and Barbuda, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Lucia, Saint Vincent and the Grenadines, American Samoa, Fiji, Kiribati, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu
Doris Duke Clinical Research Fellowship Renewal Joel Palefsky, MD Kenya, Uganda, Tanzania, Zimbabwe, India, Cambodia
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John Metcalfe, MD Zimbabwe
International Training and Education Center for Health (I-TECH) E. Michael Reyes, MD, MPH Ethiopia, Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, Namibia, South Africa, Ivory Coast, China, India, Viet Nam, Guyana, Bahamas, Barbados, Haiti, Jamaica, Trinidad and Tobago
Advancing Academic Understanding of the Private Sector, and Strengthening the Social Franchising Community of Practice Dominic Montagu, DrPH Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Mali, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea
Women, Children, and HIV Website Susan Coffey, MD Kenya, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Botswana, Lesotho, Namibia, South Africa, Swaziland, Gambia, Ghana, Liberia, Nigeria, India, Pakistan, Sri Lanka, Singapore, Philippines, United Kingdom, Anguilla, Antigua and Barbuda, Bahamas, Barbados, Cayman Islands, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Trinidad and Tobago, U.S. Virgin Islands, Northern Mariana Islands, Australia, Marshall Islands, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu
Center for AIDS Prevention Studies Stephen Morin, PhD Kenya, Mozambique, Uganda, Tanzania, Zimbabwe, Botswana, South Africa, China, India, Nepal, Thailand, Philippines, Brazil
Improving Data on Private Healthcare Use and Provision Dominic Montagu, DrPH Burundi, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Congo (Kinshasa), Sudan, South Africa, Benin, Ghana, Mali, Nigeria, Senegal, Sierra Leone, Togo, China, Bangladesh, India, Nepal, Pakistan, Cambodia, Indonesia, Viet Nam, Laos, Myanmar, Philippines, Yemen, El Salvador, Guatemala, Nicaragua, Peru, Papua New Guinea
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention Uganda, Zimbabwe
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Malawi, Uganda, Zambia, Zimbabwe, South Africa, India, Thailand, Peru, Puerto Rico
International Clinical Research Fellowships for Medical Students Joel Palefsky, MD Kenya, Uganda, Tanzania, Zimbabwe, India, Cambodia
Disclosure Intervention for Zimbabwean Parents Zimbabwe
UCSF-GIVI Center for AIDS Research (CFAR) Paul Volberding, MD Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Peru
WHO Adolescent HTC Review Update (PO# 200660799) George Rutherford, MD Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, Japan, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu
I-TECH UCSF International AETC E. Michael Reyes, MD, MPH Ethiopia, Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, Namibia, South Africa, Ivory Coast, China, India, Guyana, Bahamas, Barbados, Haiti, Jamaica, Trinidad and Tobago
External Evaluation of Elizabeth Glaser Pediatric AIDS Foundation's Prevention of Mother to Child Transmission of HIV Programme in Zimbabwe Zimbabwe
Strategic Information Technical Assistance Consortium George Rutherford, MD Ethiopia, Kenya, Malawi, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Botswana, Lesotho, Namibia, South Africa, Swaziland, Ivory Coast, Ghana, Nigeria, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, India, Cambodia, Indonesia, Viet Nam, Laos, Thailand, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Guyana, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Papua New Guinea
Accelerating progress towards Malaria Eradication: Working across Global, Regional, and National levels, and through Operational Research, to Shrink the Malaria Map Richard Feachem, DSc, PhD Zimbabwe, Swaziland
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Zimbabwe
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil, Bahamas
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD Kenya, Mozambique, Uganda, Zimbabwe, Botswana, South Africa, India, Thailand, Brazil, Peru
Oral HIV/AIDS Research Alliance Caroline Shiboski, DDS, MPH, PhD Uganda, Zimbabwe, Botswana, South Africa, India, Argentina
ACTG, AIDS Clinical Trial Research Group Diane Havlir, MD Kenya, Malawi, Uganda, Zimbabwe, Botswana, South Africa, China, India, Thailand, Brazil, Peru, Haiti
HIV Implementation Science Research Training Program John Metcalfe, MD Zimbabwe
LOC-IMPAACT Leadership Group Theodore Ruel, MD Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Argentina, Brazil
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) George Rutherford, MD Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Georgia, Iraq, Jordan, Lebanon, Syria, Turkey, Yemen, Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Slovakia, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Ecuador, Peru, Uruguay, Venezuela, Haiti, Jamaica
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG Zimbabwe
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG Zimbabwe
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU Zvavahera Chirenje, MD, FRCOG Zimbabwe
IMPAACT Yr 08 P1077 CTU MOU #2 - Parirenyatwa Zvavahera Chirenje, MD, FRCOG Zimbabwe
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North Zvavahera Chirenje, MD, FRCOG Zimbabwe
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Zimbabwe
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Zimbabwe
Harm reduction services for people who inject drugs Barrot Lambdin, PhD, MPH Mozambique, Tanzania, Zambia, Zimbabwe
The Contribution of Unsafe Blood Transfusion to HIV Transmission in Africa: A Literature Review Malika Morar, MS Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Zimbabwe
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 Zvavahera Chirenje, MD, FRCOG Zimbabwe
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 George Rutherford, MD Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Botswana, Lesotho, Namibia, South Africa, Swaziland, Western Africa, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Liberia, Mali, Mauritania, Niger, Nigeria, Sierra Leone, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, South Korea, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Georgia, Iraq, Israel, Jordan, Kuwait, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Bosnia and Herzegovina, Bulgaria, Croatia, Macedonia, Moldova, Slovenia, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Paraguay, Peru, Uruguay, Venezuela, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Dominica, Dominican Republic, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, American Samoa, Northern Mariana Islands, Guam, Fiji, Marshall Islands, Micronesia, Palau, Papua New Guinea, Samoa, Solomon Islands, Vanuatu
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Zimbabwe
Evaluation of the Population-level Impact of PMTCT Option B+ Implemented in Zimbabwe Zimbabwe
Office of the UN Special Envoy for Tuberculosis Eric Goosby, MD Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Gabon, Sao Tome and Principe, Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, Botswana, Lesotho, Namibia, South Africa, Swaziland, Benin, Burkina Faso, Cape Verde, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo, Central Asia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, Hong Kong S.A.R., China, North Korea, South Korea, Macao S.A.R., China, Mongolia, Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Sri Lanka, Brunei, Cambodia, Indonesia, Viet Nam, Laos, Malaysia, Myanmar, Singapore, Thailand, Timor-Leste, Philippines, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Caribbean, Anguilla, Turks and Caicos Islands, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Bermuda, Canada, Greenland, U.S. Virgin Islands, American Samoa, Northern Mariana Islands, Australia, Cook Islands, Guam, French Polynesia, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, New Zealand, Niue, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu
UAB-UCSF Creative and Novel Ideas in HIV Research Paul Volberding, MD Kenya, Uganda, Tanzania, Zimbabwe, South Africa, Ivory Coast, India, Cambodia, Viet Nam, Thailand, Brazil, Peru
Diagnostics, management, & transmission of MDR TB John Metcalfe, MD Zimbabwe
Executive Director of UCSF Global Health Sciences Jaime Sepulveda, MD, DSc, MPH Ethiopia, Kenya, Rwanda, Uganda, Tanzania, Zimbabwe, Mexico
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Ethiopia, Kenya, Mozambique, Uganda, Tanzania, Zimbabwe, China, Bangladesh, India, Ukraine, Guatemala, Mexico, Panama, Brazil, Chile, Peru
AIDS Malignancy Consortium (AMC) Lawrence Kaplan, MD Kenya, Malawi, Uganda, Tanzania, Zimbabwe, South Africa, India, Brazil, Australia
Evaluating Shock Index Trajectories for Improving Management of Obstetric Hemorrhage Alison El Ayadi, ScD, MPH Zambia, Zimbabwe, Egypt, Nigeria
Social Media Messaging for HIV Testing in Zimbabwe Zimbabwe
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) George Rutherford, MD Burundi, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Congo (Kinshasa), Congo (Brazzaville), Botswana, Lesotho, Namibia, South Africa, Swaziland, Ivory Coast, Ghana, Nigeria, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, China, India, Cambodia, Indonesia, Viet Nam, Laos, Thailand, Ukraine, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Suriname, Antigua and Barbuda, Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago, Papua New Guinea
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH Malawi, Uganda, Tanzania, Zambia, Zimbabwe, South Africa, India
UN Special Envoy for Tuberculosis: Strategic Priorities Eric Goosby, MD Ethiopia, Kenya, Mozambique, Tanzania, Zambia, Zimbabwe, Angola, Central African Republic, Congo (Kinshasa), Congo (Brazzaville), Lesotho, South Africa, Liberia, Nigeria, Sierra Leone, China, North Korea, Bangladesh, India, Pakistan, Cambodia, Indonesia, Viet Nam, Myanmar, Thailand, Philippines, Russia, Brazil, Papua New Guinea
Medical education and serving remote populations Yousef Turshani, MD Zimbabwe, Honduras, Nicaragua, Peru, Northern Mariana Islands
Global Health diplomacy in conflict and post conflict areas Sebastian Kevany, MPH Zimbabwe, Sudan, Thailand, Iraq
LOC-IMPAACT Leadership Group Francesca Aweeka, PharmD Malawi, Uganda, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, China, India, Thailand, Brazil
HVTN 703/HPTN 081 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG Kenya, Malawi, Mozambique, Tanzania, Zimbabwe, Botswana, South Africa
HPTN 082 - Protocol Implementation Funding Zvavahera Chirenje, MD, FRCOG Zimbabwe
HPTN 081 Protocol Funding - Development Costs Zvavahera Chirenje, MD, FRCOG Zimbabwe
General Support for the UCSF Bixby Center J. Joseph Speidel, MD, MPH Kenya, Zimbabwe
Disclosure Intervention for Zimbabwean Parents: Y 4 RPPR processed as renewal for P subaccount transition Zimbabwe
Mobile Technology for Malaria Elimination: Emma Zorensky, MS Zimbabwe, Botswana, Namibia, Swaziland
Cost-effectiveness Analysis of “Safer” Conception Strategies for HIV-Discordant Couples in Zimbabwe Carolyn Smith Hughes, MS Zimbabwe
HVTN 107 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG Zimbabwe
International Clinical Research Fellowship Christopher Stewart, MD Kenya, Uganda, Tanzania, Zimbabwe, Ghana, Liberia, Cambodia, Viet Nam
HPTN 084 Development Funding Zvavahera Chirenje, MD, FRCOG Zimbabwe
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Kenya, Malawi, Tanzania, Zimbabwe, Congo (Kinshasa), Botswana, South Africa, Ghana, Bangladesh, India, Peru
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care Kenya, Uganda, Zambia, Zimbabwe
The Bixby Center for Global Reproductive Health - Annual Research Day Conference Zvavahera Chirenje, MD, FRCOG Zimbabwe
Decision Support Platform for Malaria Interventions: Evaluate Productivity Improvements to Indoor Residual Spraying Activity by Spatial Optimizations to Disease Surveillance and Risk Monitoring (DiSARM) Platform Vikram Sridharan, MS Zimbabwe, Botswana, Namibia, South Africa
Quality Improvement Center/HEALTHQUAL Bruce D. Agins, MD, MPH Malawi, Uganda, Zimbabwe, Namibia, Nigeria, Cambodia, Viet Nam, Laos, Thailand, Haiti, Papua New Guinea
HVTN 120 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG Zimbabwe
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach George Rutherford, MD Burundi, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Lesotho, Benin, Burkina Faso, Gambia, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Sierra Leone, Togo, Kyrgyzstan, North Korea, Afghanistan, India, Nepal, Laos, Syria, Honduras
Identifying Optimal Treatment Strategies for Tuberculosis Treatment Rada Savic, PhD Kenya, Malawi, Uganda, Zimbabwe, South Africa, China, India, Viet Nam, Thailand, Brazil, Peru, Haiti
HPTN 084 Qualitative Substudy Funding Zvavahera Chirenje, MD, FRCOG Kenya, Malawi, Uganda, Zimbabwe, Botswana, South Africa, Swaziland
Enabling Better Planned Transitions of Malaria Programming from Global Fund Financing to Domestic Financing Sara Fewer Eritrea, Ethiopia, Kenya, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Uganda, Tanzania, Zambia, Zimbabwe, Cameroon, Central African Republic, Chad, Congo (Kinshasa), Congo (Brazzaville), Equatorial Guinea, Benin, Burkina Faso, Ivory Coast, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Afghanistan, Bangladesh, India, Nepal, Brunei, Cambodia, Myanmar, Honduras, Cuba, Haiti

Active Investigators: 1